S4 Capital PLC (SFOR)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 53.60 |
|---|---|
| 52-week range | 15.70 – 57.00 |
| Return, 1 month / 3 months | +17.8% / +46.9% |
| Return, 1 year / 3 years | +130.7% / +1.1% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 74.2% |
| Worst drawdown (1 year) | -32.9% |
| Average daily value traded | 118.03M GBX |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
S4 Capital is a digital advertising and marketing services company based in London. Through its Media.Monks brand, it brings together creative content, media planning and buying, and technology services for clients around the world. The group works with major advertisers and brands, helping them plan and produce digital campaigns and manage their marketing across online channels. Its services combine creative work with data and technology, and it operates internationally with staff in many countries.
S4 Capital PLC trades under the code SFOR on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
S4 Capital PLC (SFOR) trades on the London Stock Exchange in UK. It last closed at GBX 53.60 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 440 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 130.7% and over the last three months it rose 46.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 49.7% | ||
| From 52-week high | -1.7% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 46.9% | ||
| 6-month return | 39.0% | ||
| 12-month return, skipping the last month | 95.8% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 74.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.9% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 118.03M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +10.1% |
|---|---|
| 1 month | +17.8% |
| 3 months | +46.9% |
| 6 months | +39.0% |
| 1 year | +130.7% |
| 3 years | +1.1% |
| 5 years | −91.9% |
Signals
| 50-day / 200-day average | 47.60 / 35.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0135 |
| 4 Jun 2026 | GBP 0.0110 |
| 5 Jun 2025 | GBP 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.